Stroke prevention in atrial fibrillation: An Asian perspective

Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin

(2013) Stavros Apostolakis et al.   CHEST

Optimal International Normalized Ratio for Atrial Fibrillation in Asians and Japanese

(2013) Kang-Ling Wang et al.   CIRCULATION JOURNAL

Target International Normalized Ratio Values for Preventing Thromboembolic and Hemorrhagic Events in Japanese Patients With Non-Valvular Atrial Fibrillation

(2013) Hiroshi Inoue et al.   CIRCULATION JOURNAL

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

(2013) B. P. Krijthe et al.   EUROPEAN HEART JOURNAL

Stroke prevention in atrial fibrillation—An Asian stroke perspective

(2013) Hung-Fat Tse et al.   HEART RHYTHM

Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: The Chin-Shan Community Cohort Study

(2013) Gregory Y.H. Lip et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Current status of clinical background of patients with atrial fibrillation in a community-based survey: The Fushimi AF Registry

(2013) Masaharu Akao et al.   Journal of Cardiology

The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation

(2013) Vanessa Roldán et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin

(2013) Ida Ehlers Albertsen et al.   STROKE

Dabigatran Versus Warfarin

(2013) Masatsugu Hori et al.   STROKE

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

(2013) Pilar Gallego et al.   THROMBOSIS AND HAEMOSTASIS

General mechanisms of coagulation and targets of anticoagulants (Section I)

(2013) Steen Husted et al.   THROMBOSIS AND HAEMOSTASIS

Comparison of the CHADS2, CHA2DS2 -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial

(2013) Stavros Apostolakis et al.   THROMBOSIS AND HAEMOSTASIS

Vitamin K antagonists in heart disease: Current status and perspectives (Section III)

(2013) Raffaele Caterina et al.   THROMBOSIS AND HAEMOSTASIS

The Global Burden of Atrial Fibrillation and Stroke

(2012) Gregory Y.H. Lip et al.   CHEST

The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy

(2012) Michiel Coppens et al.   EUROPEAN HEART JOURNAL

Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: Would the novel oral anticoagulants have an impact?

(2012) Yutao Guo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Atrial fibrillation management in Asia: From the Asian expert forum on atrial fibrillation

(2012) Chern-En Chiang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation

(2012) Yutao Guo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study

(2012) Christian Torp-Pedersen et al.   THROMBOSIS AND HAEMOSTASIS

Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation

(2012) Ron Pisters et al.   THROMBOSIS AND HAEMOSTASIS

Insights Into Management of Atrial Fibrillation in Asia Pacific Gained From Baseline Data from REgistry on Cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) Registry

(2011) John Amerena et al.   AMERICAN JOURNAL OF CARDIOLOGY

Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation—A nation wide database analysis

(2011) Lian-Yu Lin et al.   ATHEROSCLEROSIS

Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry

(2011) P Gabriel Steg et al.   HEART

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients

(2011) Arlene Gallagher et al.   THROMBOSIS AND HAEMOSTASIS

Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke

(2011) Emma Wallace et al.   THROMBOSIS AND HAEMOSTASIS

Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008)

(2010) JCS Joint Working Group   CIRCULATION JOURNAL

Relationship Between CHADS2 Score and Ischemic Stroke During Rhythm Control Therapy for Paroxysmal Atrial Fibrillation

(2010) Takashi Komatsu et al.   International Heart Journal

Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis

(2010) Charlotte JJ van Asch et al.   LANCET NEUROLOGY

The RecordAF Study: Design, Baseline Data, and Profile of Patients According to Chosen Treatment Strategy for Atrial Fibrillation

(2009) Jean-Yves Le Heuzey et al.   AMERICAN JOURNAL OF CARDIOLOGY

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme

(2008) Stephan Rietbrock et al.   AMERICAN HEART JOURNAL

Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation

(2008) Yi Wan et al.